The feasibility study aims to develop and test two telemonitoring designs for people with non-insulin-dependent T2D with the goal of identifying the most suitable telemonitoring intervention for a planned future large-scale randomized controlled trial. This evidence concerns the gene INS and type 2 diabetes mellitus.